Literature DB >> 20693540

Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients.

Paivi M Miettunen, Aru Narendran, Aarthi Jayanthan, Edward M Behrens, Randy Q Cron.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20693540     DOI： 10.1093/rheumatology/keq218

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  85 in total

Review 1.  The rheumatology/hematology interface: CAPS and MAS diagnosis and management.

Authors:  John M Gansner; Nancy Berliner
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 2.  Macrophage activation syndrome complicating rheumatic diseases in adults: case-based review.

Authors:  Mayan Gilboa; Gil Bornstein; Ilan Ben-Zvi; Chagai Grossman
Journal:  Rheumatol Int       Date:  2019-07-31       Impact factor: 2.631

3.  Enterovirus-Associated HLH: Addition of Anakinra to IVIG and Corticosteroids.

Authors:  Simon Jonathan Hardman; Gidado Tukur; Catherine Waruiru
Journal:  J Clin Immunol       Date:  2019-05-19       Impact factor: 8.317

4.  An atypical presentation of adult-onset Still's disease complicated by pulmonary hypertension and macrophage activation syndrome treated with immunosuppression: a case-based review of the literature.

Authors:  Mili V Mehta; Daniel K Manson; Evelyn M Horn; Jennifer Haythe
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

5.  Resolution of secondary hemophagocytic lymphohistiocytosis after treatment with the JAK1/2 inhibitor ruxolitinib.

Authors:  Scott R Goldsmith; Sana Saif Ur Rehman; Cara L Shirai; Kiran Vij; John F DiPersio
Journal:  Blood Adv       Date:  2019-12-10

Review 6.  Sepsis: frontiers in supportive care, organisation and research.

Authors:  Anders Perner; Andrew Rhodes; Bala Venkatesh; Derek C Angus; Ignacio Martin-Loeches; Jean-Charles Preiser; Jean-Louis Vincent; John Marshall; Konrad Reinhart; Michael Joannidis; Steven M Opal
Journal:  Intensive Care Med       Date:  2017-01-27       Impact factor: 17.440

7.  2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.

Authors:  Sarah Ringold; Pamela F Weiss; Timothy Beukelman; Esi Morgan DeWitt; Norman T Ilowite; Yukiko Kimura; Ronald M Laxer; Daniel J Lovell; Peter A Nigrovic; Angela Byun Robinson; Richard K Vehe
Journal:  Arthritis Rheum       Date:  2013-10

Review 8.  Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Antiinflammatory Drugs and/or With Active Spinal Lesions.

Authors:  Yongdong Zhao; Eveline Y Wu; Melissa S Oliver; Ashley M Cooper; Matthew L Basiaga; Sheetal S Vora; Tzielan C Lee; Emily Fox; Gil Amarilyo; Sara M Stern; Jeffrey A Dvergsten; Kathleen A Haines; Kelly A Rouster-Stevens; Karen B Onel; Julie Cherian; Jonathan S Hausmann; Paivi Miettunen; Tania Cellucci; Farzana Nuruzzaman; Angela Taneja; Karyl S Barron; Matthew C Hollander; Sivia K Lapidus; Suzanne C Li; Seza Ozen; Hermann Girschick; Ronald M Laxer; Fatma Dedeoglu; Christian M Hedrich; Polly J Ferguson
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-07-12       Impact factor: 4.794

Review 9.  Genetic defects in cytolysis in macrophage activation syndrome.

Authors:  Mingce Zhang; Edward M Behrens; T Prescott Atkinson; Bita Shakoory; Alexei A Grom; Randy Q Cron
Journal:  Curr Rheumatol Rep       Date:  2014       Impact factor: 4.592

Review 10.  [Hemophagocytic lymphohistiocytosis : A diagnostic challenge on the ICU].

Authors:  G Lachmann; P La Rosée; T Schenk; F M Brunkhorst; C Spies
Journal:  Anaesthesist       Date:  2016-10       Impact factor: 1.041
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.